临床数据分析市场 - 预测 2023-2028

临床数据分析市场预计到 2021 年将达到 255.96 亿美元，预测期内復合年增长率为 25.74%，到 2028 年将达到 1272.2 亿美元。

临床数据分析收集、存储、分析和增强敏感临床数据在临床研究中的适用性，使护理人员能够为患者提供预防性和个性化护理。这是实现并从而提高患者护理整体质量的关键一步。 向数字支付模式迁移的趋势和电子病历 (EMR) 的普及正在推动世界许多地区该市场的增长。 对改进和具有成本效益的医疗保健的需求不断增长，推动了对临床数据分析的需求。 随着主要市场参与者在安全方面投入巨资，数字平台和渠道的安全性不断提高，医疗保健行业也进行了大量投资，使得临床数据分析的采用在预测期内继续获得动力，推动了市场的增长。 从地域上看，由于有利的政府政策和对大数据分析的巨额投资，北美在全球市场中占有很大的市场份额。

该研究根据产品、部署、最终用户和地理位置等各个细分市场进行市场细分。 首先，市场概述详细介绍了关键驱动因素和挑战。 然后利用波特五力模型对临床数据分析行业进行全面分析。 然后，价值链分析可以确定哪些公司属于不同流程并为不同领域做出贡献。

它还提供了有关发展、趋势、行业政策和影响临床数据分析市场的政策的深入信息。 此外，该研究还分析了临床数据分析领域的整体监管框架，并使利益相关者更好地了解影响整体市场格局的关键因素。

《临床数据分析市场 - 2023-2028 年预测》是一份全面的最新报告。 我们向管理层和感兴趣的利益相关者提供关键市场信息，并让他们了解关键市场信息。 我们还分析了主要市场参与者的竞争格局和详细策略，并将其绘製在我们的供应商矩阵中的四个像限中：领导者、追随者、挑战者和利基市场。

临床数据分析市场报告的研究范围和覆盖范围如下：

• 临床数据分析市场前景的市场数据表和图表，包括市场驱动因素、限制因素、搬运工、行业价值链分析市场评估等部分，按产品分类为软件和服务。 本地和云部署模型的详细市场趋势、分析和图形表示。 对临床数据分析市场按最终用户细分为製药公司、医疗机构、研究机构和政府机构的深入分析。 它提供了按地区（北美、南美、欧洲、中东/非洲和亚太地区）对临床数据分析解决方案和服务的360度需求视图，并进一步细分了该地区的主要国家。

内容

第一章简介

• 市场概览
• 市场定义
• 调查范围
• 市场细分
• 货币
• 先决条件
• 基准年和预测年时间表

第 2 章研究方法

• 调查数据
• 调查设计
• 验证

第 3 章执行摘要

• 调查要点

第 4 章市场动态

• 市场驱动因素
• 市场製约因素
• 波特五力分析
• 行业价值链分析

第 5 章临床数据分析市场：按产品

• 简介
• 软件
• 服务

第 6 章临床数据分析市场：按部署模型

• 简介
• 本地
• 云

第 7 章临床数据分析市场：按最终用户划分

• 简介
• 製药公司
• 医疗机构
• 研究机构
• 政府机构

第 8 章临床数据分析市场：按地区

• 简介
• 北美
  • 美国
  • 加拿大
  • 墨西哥
• 南美洲
  • 巴西
  • 阿根廷
  • 其他
• 欧洲
  • 英国
  • 德国
  • 法国
  • 西班牙
  • 其他
• 中东和非洲
  • 沙特阿拉伯
  • 阿拉伯联合酋长国
  • 以色列
  • 其他
• 亚太地区
  • 日本
  • 中国
  • 印度
  • 韩国
  • 印度尼西亚
  • 泰国
  • 其他

第 9 章竞争格局与分析

• 主要公司及战略分析
• 新兴公司和市场盈利能力
• 合併、收购、协议与合作
• 供应商竞争力矩阵

第 10 章公司简介

• McKesson Corporation
• Optum, Inc.
• IBM
• Oracle
• SAS Institute, Inc.
• IQVIA
• Elsevier
• Allscripts Healthcare Solutions, Inc.
• Medical Information Technology Inc.
• CareCloud Corporation

The clinical data analytics market was valued at US$25.596 billion in 2021 and is projected to expand at a CAGR of 25.74% over the forecast period to reach US$127.220 billion by 2028.

Clinical data analytics is an important phase in clinical research that involves the collection, storage, and analysis of sensitive clinical data to enhance its applicability, thus aiding caregivers in providing preventive and personalized care to the patients, thereby improving the overall quality of patient care. Shifting trends toward digital payment models and the growing popularity of Electronic Medical Records (EMRs) are driving the growth of this market in many regions across the globe. Rising demand for improved and cost-effective healthcare is increasing the demand for clinical data analytics. As the security of digital platforms and channels continues to increase owing to huge amounts being poured into security by major market players, and significant investments continue to stream into the healthcare industry, the adoption of clinical data analytics will continue to gain momentum over the projected period, thus augmenting the growth of this market. Geographically, North America holds a significant market share in the global market on account of favorable government policies and huge investments in big data analytics.

This research study examines the clinical data analytics market based on various segments: product, deployment, end-user, and geography. First, a brief overview of the market details key driving factors and challenges. Next, Porter's five forces model analyzes the Clinical data analytics industry comprehensively. This is followed by industry value chain analysis which determines the companies which are part of the different processes and contributing to various sectors.

The study also presents in-depth information concerning the development, trends, and industry policies and regulations affecting the clinical data analytics market. Moreover, the research study analyzes the overall regulatory framework of the Clinical data analytics sector, offering stakeholders a better understanding of the key factors influencing the overall market environment.

Clinical data analytics market - Forecasts from 2023 to 2028 are a comprehensive and latest report. It provides vital market information to executives and interested stakeholders to enable them to get vital market information. The report also analyzes the competitive landscape and details strategies of key market players and also plots them on our vendor matrix in four quadrants: leader, follower, challenger, and niche.

The scope and coverage of the clinical data analytics market report are as below:

• Clinical data analytics market data tables and charts
• Market outlook with sections on drivers, restraints, Porter's, and industry value chain analysis
• Market assessment by product into software and services.
• Detailed market trends, analysis, and graphical representation by deployment model into on-premise and cloud.
• In-depth analysis of the clinical data analytics market by end-user into pharmaceutical companies, healthcare organizations, research organizations, and government organizations.
• A 360 degree view of the demand for clinical data analytics solutions/services across different geographies (North America, South America, Europe, Middle East and Africa, and Asia Pacific) with further breakdown for key countries within those regions.

Different segments covered under the clinical data analytics market report are as below:

By Product

• Software
• Services

By Deployment Model

• On-Premise
• Cloud

By End-User

• Pharmaceutical Companies
• Healthcare Organizations
• Research Organizations
• Government Organizations

By Geography

• North America
  • United States
  • Canada
  • Mexico
• South America
  • Brazil
  • Argentina
  • Others
• Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others
• Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

• 1.1. Market Overview
• 1.2. Market Definition
• 1.3. Scope of the Study
• 1.4. Market Segmentation
• 1.5. Currency
• 1.6. Assumptions
• 1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

• 2.1. Research Data
• 2.2. Research Design
• 2.3. Validation

3. EXECUTIVE SUMMARY

• 3.1. Research Highlights

4. MARKET DYNAMICS

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis

5. CLINICAL DATA ANALYTICS MARKET BY PRODUCT

• 5.1. Introduction
• 5.2. Software
• 5.3. Services

6. CLINICAL DATA ANALYTICS MARKET BY DEPLOYMENT MODEL

• 6.1. Introduction
• 6.2. On-Premise
• 6.3. Cloud

7. CLINICAL DATA ANALYTICS MARKET BY END-USER

• 7.1. Introduction
• 7.2. Pharmaceutical Companies
• 7.3. Healthcare Organizations
• 7.4. Research Organizations
• 7.5. Government Organizations

8. CLINICAL DATA ANALYTICS MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. United States
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. United Kingdom
  • 8.4.2. Germany
  • 8.4.3. France
  • 8.4.4. Spain
  • 8.4.5. Others
• 8.5. Middle East and Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. UAE
  • 8.5.3. Israel
  • 8.5.4. Others
• 8.6. Asia Pacific
  • 8.6.1. Japan
  • 8.6.2. China
  • 8.6.3. India
  • 8.6.4. South Korea
  • 8.6.5. Indonesia
  • 8.6.6. Thailand
  • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Emerging Players and Market Lucrativeness
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Vendor Competitiveness Matrix

10. COMPANY PROFILES

• 10.1. McKesson Corporation
• 10.2. Optum, Inc.
• 10.3. IBM
• 10.4. Oracle
• 10.5. SAS Institute, Inc.
• 10.6. IQVIA
• 10.7. Elsevier
• 10.8. Allscripts Healthcare Solutions, Inc.
• 10.9. Medical Information Technology Inc.
• 10.10. CareCloud Corporation